Company No: 07679157 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	Jason Cawley
	Dr David Edward Jackson
	Alexander Roger William Marshall
	Iain Fenton Rae

REGISTERED OFFICE	Oxford House
	15 - 17 Mount Ephraim Road
	Tunbridge Wells
	TN1 1EN
	United Kingdom

COMPANY NUMBER

07679157 (England and Wales)

ACCOUNTANT	Synergee
	Pluto House
	6 Vale Avenue
	Tunbridge Wells
	TN1 1DJ

	Note	2025		2024
		£		£
Fixed assets
Intangible assets	3	2,551,782		2,126,863
Tangible assets	4	5,306		8,860
		2,557,088		2,135,723
Current assets
Debtors	5	143,001		57,307
Cash at bank and in hand	6	68,661		11,871
		211,662		69,178
Creditors: amounts falling due within one year	7	( 187,229)		( 155,203)
Net current assets/(liabilities)		24,433		(86,025)
Total assets less current liabilities		2,581,521		2,049,698
Net assets		2,581,521		2,049,698
Capital and reserves
Called-up share capital	8	74		44
Share premium account		2,217,915		1,769,295
Profit and loss account		363,532		280,359
Total shareholders' funds		2,581,521		2,049,698

For the financial year ending 30 June 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Seon Diagnostics Ltd (registered number: 07679157) were approved and authorised for issue by the Board of Directors on 12 September 2025. They were signed on its behalf by:

Iain Fenton Rae Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Seon Diagnostics Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Oxford House, 15 - 17 Mount Ephraim Road, Tunbridge Wells, TN1 1EN, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets

not amortised

Research and development

Research expenditure is written off as incurred. Development expenditure is also written off, except where the directors are satisfied as to the technical, commercial and financial viability of individual projects. In such cases, the identifiable expenditure is capitalised as an intangible asset and amortised over the period during which the Company is expected to benefit. This period is between three and five years. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc.

4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Government grants

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	6		8

3. Intangible assets

	Other intangible assets		Total
	£		£
Cost
At 01 July 2024	2,126,863		2,126,863
Additions	424,919		424,919
At 30 June 2025	2,551,782		2,551,782
Accumulated amortisation
At 01 July 2024	0		0
At 30 June 2025	0		0
Net book value
At 30 June 2025	2,551,782		2,551,782
At 30 June 2024	2,126,863		2,126,863

4. Tangible assets

	Plant and machinery etc.		Total
	£		£
Cost
At 01 July 2024	27,109		27,109
At 30 June 2025	27,109		27,109
Accumulated depreciation
At 01 July 2024	18,249		18,249
Charge for the financial year	3,554		3,554
At 30 June 2025	21,803		21,803
Net book value
At 30 June 2025	5,306		5,306
At 30 June 2024	8,860		8,860

5. Debtors

	2025		2024
	£		£
Other debtors	143,001		57,307

6. Cash and cash equivalents

	2025		2024
	£		£
Cash at bank and in hand	68,661		11,871

7. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	29,708		58,954
Other taxation and social security	7,667		22,881
Other creditors	149,854		73,368
	187,229		155,203

8. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
68,586 Ordinary shares of £ 0.001 each (2024: nil shares)	68.59		0
5,858 G Ordinary shares of £ 0.001 each (2024: nil shares)	5.86		0
Nil ordinary shares (2024: 43,820 shares of £ 0.001 each)	0		43.82
	74.45		43.82